Can friends and family help older cancer patients feel better? new study aims to find out
NCT ID NCT07393529
First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This pilot study tests a program called SONATA that helps older adults (65+) with advanced cancer strengthen their social connections. The program includes goal-setting, mapping out one's support network, and improving communication with loved ones. Researchers want to see if the program is practical and acceptable for patients, and whether it improves emotional and social quality of life. 70 participants will be randomly assigned to SONATA or standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- SONATA behavioral intervention (goal-setting, network mapping, communication skills)
- What this could lead to
- If it works, this could provide a practical way to improve emotional and social well-being for older adults facing advanced cancer.
- What could go wrong
- This is a small pilot study (70 people) testing feasibility, not effectiveness. The intervention may not show clear benefits or be too complex for some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Mar 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patients Inclusion criteria: * Age ≥65 years * A diagnosis of advanced or likely incurable cancer, as determined by the primary oncologist * Able to speak English * Able to provide informed consent Exclusion criteria: * Any psychiatric or cognitive impairments interfering with participation as determined by the oncology team * Unwilling to complete study procedures Social Network Members (if available, for intervention arm only) Inclusion criteria: * Age ≥18 years * Identified as an SN member by the patient in the intervention arm * Able to speak English * Able to provide informed consent Exclusion criteria: • Unwilling to complete study procedures
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Rochester
RECRUITINGRochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking symptoms improve care for children with advanced cancer?
- Can a new pill boost Immunotherapy's power against advanced tumors?
- Can a DNA vaccine train the immune system to hunt down HER3-Positive cancers?
- Can a new antibody help the immune system fight Hard-to-Treat tumors?
- A 10-minute video may change how doctors treat malnutrition in the elderly
- Can an AI chatbot lift the spirits of advanced cancer patients?